How should I use Welireg(Belzutifan)?

WELIREG is administered orally once daily at a standard dose, with provisions for dose adjustments based on adverse reactions and missed dose instructions.

Dosage and Administration Guidelines for WELIREG

1. Recommended dose: 120 mg orally once daily.

2. Administration: With or without food, at the same time each day. Tablets should be swallowed whole, not chewed, crushed, or split.

3. Missed dose: Take as soon as possible on the same day. Resume regular schedule the next day. Do not take extra tablets.

4. Vomiting: Do not retake the dose. Take the next dose on the next day.

5. Duration: Until disease progression or unacceptable toxicity.

Dose reductions for adverse reactions:

1. First reduction: 80 mg once daily.

2. Second reduction: 40 mg once daily.

3. Third reduction: Permanently discontinue.

Belzutifan(Welireg)
Adult patients with renal cell carcinoma, central nervous system hemangioblastoma, or pancreatic neuroendocrine tumors.
RELATED ARTICLES
What is the dosage of Belzutifan and how to take it?

Belzutifan is an oral tablet approved for the treatment of patients with renal cell carcinoma (RCC), central nervous...

Tuesday, June 24th, 2025, 13:29
The role and efficacy of Belzutifan

Belzutifan(Welireg) is a novel therapeutic drug for tumors associated with von Hippel-Lindau (VHL) syndrome. It...

Tuesday, June 24th, 2025, 13:20
Dosage of Belzutifan

Belzutifan(Welireg) is a novel therapeutic drug for tumors associated with von Hippel-Lindau (VHL) syndrome. It...

Tuesday, June 24th, 2025, 13:06
/ 1
3 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved